Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 2, Multiple-Dose Study of The Efficacy and Safety of Wafermine™ (Sublingual Ketamine) in Participants Experiencing Acute Post-Operative Bunionectomy or Abdominoplasty Pain

NCT03246971 is registered in ClinicalTrials.gov with iX Biopharma Ltd. as lead sponsor.

NCT NCT03246971
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03246971 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 2, Multiple-Dose Study of The Efficacy and Safety of Wafermine™ (Sublingual Ketamine) in Participants Experiencing Acute Post-Operative Bunionectomy or Abdominoplasty Pain
Lead sponsor
iX Biopharma Ltd.
Phase
Phase 2
Overall status
Completed
Start date
August 24, 2017
Completion date
July 17, 2018
Enrollment
125 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

abdominoplasty, acute pain, bunion